Differential diagnosis and pharmacotherapy of juvenile mania - A review;Differenzielle diagnostik und pharmakotherapie der juvenilen manie - Eine übersicht

Psychiatrische Praxis, Supplement

Volumn 33, Issue 1, 2006, Pages

  Braun Scharm, Hellmuth ^a   Bilke, Oliver ^a  

^a VIVANTES HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

BIPOLAR DISORDER; CHILD PSYCHIATRY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; MANIA; PROGNOSIS; QUALITY OF LIFE; RAPID CYCLING BIPOLAR DISORDER; REVIEW; SCHIZOPHRENIA; SOCIAL ASPECT; SYSTEMATIC REVIEW; UNITED STATES;

EID: 33645105965     PISSN: 16118332     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-915327     Document Type: Review

References (95)

1. Braun-Scharm H, Leeners T. Juvenile Manien - eine Literaturü bersicht. Forum Kinder- und Jugendpsychiatrie 2005; 3: 23-55
2. Carlson GA, Kashani JH. What is new in bipolar and major depressive disorder in children and adolescents. Child Adolesc Psychiat Clin North Am 2002; 11: XV-XXII
3. Conus P, McGorry PD. First-episode mania: a neglected priority for early intervention. Aust N Z J Psychiatry 2002; 36: 158-172
4. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537
5. Akiskal HS. Validating "hard" and "soft" phenotypes within the bipolar spectrum: continuity or discontinuity? J Affect Disord 2003; 73: 1-5
6. Nissen G. Affektive Psychosen in der Adoleszenz. Nervenarzt 1975; 46: 302-307
7. Findling RL, Gracious BL, McNamara NK, Youngstrom EA, Demeter CA, Branicky LA, Calabrese JR. Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipol Disord 2001; 3: 202-210
8. Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997; 36/9: 1168-1176
9. Jones PM, Berney TP. Early onset rapid cycling bipolar affective disorder. J Child Psychol Psychiatry 1987; 28/5: 731-738
10. Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, Endicott J. The significance of psychotic features inmanic episodes: a report from the NIMH collaborative study. J Affect Disord 2001; 67: 79-88
11. Shiratsuchi T, Takahashi N, Suzuki T, Abe K. Depressive episodes of bipolar disorder in early teenage years: changes with increasing age and the significance of IQ. J Affect Disord 2000; 58: 161-166
12. Pavuluri MN, Birmaher B, Naylor MW. Pediatric bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2005; 44 (9): 846-871
13. Todd RD, Botteron KN. Etiology and genetics of early-onset mood disorders. Child Adolesc Clin North Am 2002; 11: 499-518
14. Bieling PJ, MacQueen GM, Marriot MJ, Robb JC, Begin H, Joffe RT, Young LZ. Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms. Bipol Disord 2003; 5: 14-21
15. Birmaher B, Kennah A, Brent D, Ehmann M, Bridge J, Axelson D. Is bipolar disorder specifically associated with panic disorder in youths? J Clin Psychiatry 2002; 63/5: 414-419
16. Brieger P, Ehrt U, Marneros A. Frequency of comorbid personality disorders in bipolar and unipolar affective disorders. Comprehens Psychiatry 2003; 44/1: 28-34
17. Frank E, Cyranowski JM, Rucci P, Shear K, Fagiolini A, Thase ME, Cassano GB, Grochocinski VJ, Kostelnik B, Kupfer DJ. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry 2002; 59: 905-911
18. Johnson JG, Cohen P, Brook JS. Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community based longitudinal investigation. Am J Psychiatry 2000; 157: 1679-1681
19. Kay JH, Altshuler LL, Ventura J, Mintz J. Impact of axis II comorbidity on the course of bipolar illness in men: a retrospective chart review. Bipol Disord 2002; 4: 237-242
20. Masi G, Toni CT, Perugi G, Mucci M, Millepiedi S, Akiskal HS. Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Can J Psychiatry 2001; 46: 797-802
21. Wozniak J, Biederman J, Faraone SV, Blier H, Monuteaux MC. Heterogeneity of childhood conduct disorder: further evidence of a subtype of conduct disorder linked to bipolar disorder. J Affect Dis 2001; 64: 121-131
22. Biederman J, Wozniak J, Kiely K, Ablon S, Faraone S, Mick E, Mundy E, Kraus I. CBCL clinical scales discriminate prepubertal children with structured interview-derived diagnosis of mania from those with ADHD. J Am Acad Child Adolesc Psychiatry 1995; 34/4: 464-471
23. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry 2000; 48: 458-466
24. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am Acad Child Adolesc Psychiatry 1997a; 36/10: 1378-1387
25. Faraone SV, Biederman J, Wozniak J, Mundy E, Mennin D, O'Donnell D. Is comorbidity with ADHD a marker for juvenile-onset mania? J Am Acad Adolesc Psychiatry 1997b; 36/8: 1046-1055
26. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipor Disord 2000; 2: 281-293
27. Kim EY, Miklowitz DJ. Childhood mania, attention deficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas. Bipol Disord 2002; 4: 215-225
28. Kent L, Craddock N. Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder? J Affect Disord 2003; 73: 211-221
29. Geller B, CraneyJL, Bolhofner K, Nickelsburg MJ, Williams M, Zimerman B. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar and early adolescent bipolar disorder phenotype. Am J Psychiatry 2002a; 159: 927-933
30. Koukopoulos A, Sani G, Koukopoulos AE, Minnai GP, Girardi P, Pani L, Albert MJ, Reginaldi D. Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affect Disord 2003; 73: 75-85
31. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RMA. The national Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disorder 1994; 31: 281-294
32. Strober M, Schmidt-Lackner S, Freeman R, Bower S, Lampert C, DeAntonio M. Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995; 34/6: 724-731
33. Lewinsohn PM, Seeley JR, Buckley ME, Klein DN. Bipolar disorder in adolescence and young adulthood. Child Adolesc Psychiat North Am 2002; 11: 461-475
34. Werry JS, McClellan JM. Predicting outcome in child and adolescent (early onset) schizophrenia and bipolar disorder. J Am Acad Child Adolesc Psychiatry 1992; 31/1: 147-150
35. Benazzi F. Age at onset of bipolar II depressive mixed state. Psychiatry Res 2001; 103: 229-235
36. Benazzi F. Bipolar II depressive mixed state: finding a useful definition. Comprehens Psychiatry 2003; 44/1: 21-27
37. Benazzi F, Akiskal HS. Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. J Affect Disord 2003; 73: 33-38
38. Angst J, Gamma A. A new bipolar spectrum concept: a brief review. Bipol Disord 2002; 4 suppl 1: 11-14
39. Perugi G, Akiskal HS, Micheli C, Toni C, Madaro D. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J Affect Disord 2001; 67: 105-114
40. Perugi G, Akiskal HS. The soft pectrum redefined: focus on the cyclothymic, anxious-sensitive, impuls-dyscontrol, and binge-eating connection inbipolar II and releated conditions. Psychiat Clin North Am 2002; 25: 713-737
41. Perry A, Tarrier N, Morriss E, Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. Brit Med J 1999; 318: 149-153
42. Kowatch RA, Frisatd M, Birmaher B, Wagner KD, Findling RL, Hellander M and the Child Psychiatric workgroup on bipolar disorder. Treatment Guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005; 44 (3): 213-235
43. Davanzo PA, McCracken JT. Mood stabilizer in the treatment of juvenile bipolar disorder. Child Adolesc Psychiat Clin North Am 2000; 9/1: 159-182
44. Montgomery SA, Keck PE. First international exchange on bipolar disorder. J Affect Disord 2000; 59: S81-S88
45. Botteron KN, Geller B. Pharmacologic treatment of childhood and adolescent mania. Child Adolesc Psychiat Clin North Am 1995; 4/2: 283-304
46. James ACD, Javaloyes AM. Practitioner review: the treatment of bipolar disorder in children and adolescents. J Child Psychol Psychiatry 2001; 42/4: 439-449
47. Schou M. Lithium treatment at 52. J Affect Disord 2001; 67: 21-32
48. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. The cochrane database of systematic reviews. Lithium for maintenance treatment of mood disorders. 2003; Volume (1)
49. Wagner KD, Weller EB, Carlson GA, Sachs G, Biederman J, Frazier JA, Wozniak P, Tracy K, Weller R, Bowden C. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002; 41/10: 1224-1230
50. Barrios C, Chaudhry TA, Goodnick PJ. Rapid cycling bipolar disorder. Expert Opin Pharmacother 2001; 2/12: 1963-1973
51. Post RM, Frye MA, Denicoff KD, Leverich GS, Dunn RT, Osuch EA, Speer AM, Obrocea G, Jajodia K. Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review. Bipol Disord 2000; 2: 305-315
52. Greil W, Kleindienst N. Lithium versus Carbamazepin in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 1999a; 14/5: 283-285
53. Greil W, Kleindienst N. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 1999b; 14/5: 277-281
54. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000; 39/6: 713-720
55. Keck PE, Mendlewitz J, Calabrese JR, Fawcett J, Suppes T, Vestergaard A, Carbonell C. A review of randomized, controlled clinical trials in acute mania. J Affect Disord 2000; 59: S31-S37
56. Yatham LN, Kusumakar V, Calabrese JR, Scarrow G, Kroeker G. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations. J Clin Psychiatry 2002; 63: 275-283
57. Bowden CL, Karren NU. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother 2002; 3/10: 1513-1519
58. Calabrese JR, Melvin DS, Shelton MD, Rapport DJ, Kimmel SE. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002a; 63, suppl 3: 5-9
59. Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. ANN J Psychiatry 2000; 12/1: 5-10
60. MacDonald KJ, Young LT. Newer antiepileptic drugs in bipolar disorder. CNS Drugs 2002; 16/8: 549-562
61. Zerjav-Lacombe S, Tabarsi E. Lamotrigine: a review of clinical studies in bipolar disorders. Can J Psychiatry 2001; 46: 328-333
62. Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE, Elhaj O. Long-term treatment of bipolar disorder with lamotrigine. J Clin Psychiatry 2002b; 63, suppl 10: 18-22
63. Grunze H, Walden J. Relevance of new and newly rediscovered anti-convulsants for atypical forms of bipolar disorder. J Affect Disord 2002; 72: S15-S21
64. Overstreet K, Costanza C, Behling C, Hassanin T, Masliah E. Fatal progressive hepatic necrosis associated with lamotrigine treatment. Dig Dis Sci 2002; 47/9: 1921-1925
65. Chengappa KNR, Gershon S, Levine J. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipol Disord 2001; 3: 215-232
66. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 2001a; 62/7: 565-569
67. Guille C, Sachs G. Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions. Progr Neuro Psychopharmacol Biol Psychiatry 2002; 26: 1035-1039
68. Suppes T. Review of the use of topiramate for treatment of bipolar disorders. J Clin Psychopharmacol 2002; 22: 599-609
69. Carta MG, Hardoy MC, Hardoy MJ, Grunze H, Carpiniello B. The clinical use of gabapentin in bipolar spectrum disorders. J Affect Disord 2003; 75: 83-91
70. Hamrin V, Bailey K. Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11/3: 301-309
71. Hellewell JSE. Oxcarbazepin (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability. J Affect Disord 2002; 72: S23-S34
72. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: aplacebo-controlled trial of adjunctive therapy. Bipol Disord 2000; 2: 249-255
73. Wang PW, Santosa C, Schmacher M, Winsberg ME, Strong C, Ketter TA. Gabapentin augmentation therapy in bipolar depression. Bipol Disord 2002; 4: 296-301
74. Miller DS, Yatham LN, Lam RW. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. J Clin Psychiatry 2001; 62: 975-980
75. Chengappa KNR, Baker RW, Shao L, Tohen M, Gershon S, Kupfer DJ. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials für bipolar mania. Bipolar Disord 2003; 5: 1-5
76. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double blind, randomized, placebo-controlled study of Quetiapine as adjunctive treatment for adlescent mania. J Am Acad Child Adolesc Psychiatry 2002; 41/10: 1216-1223
77. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzales-Heydrich J, Risser RC, Nowlin ZM. A prospective open-label treatment trial of Olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11/3: 239-250
78. Khouzam HR, El-Gabalawi F. Treatment of bipolar I disorder in an adolescent with olanzapine. J Child Adolesc Psychopharmacol 2000; 10/2: 147-151
79. Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A. Efficacy of olanzapine in acute bipolar mania. Arch Gen Psychiatry 2000; 57: 841-849
80. Vieta E, Parramon G, Padrell E, Nieto E, Martinez-Arán A, Corbella B, Colom F, Reinares M, Goikolea JM, Torrent C. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipol Disord 2002b; 4: 335-340
81. Aubry JM, Simon AE, Bertschy GB. Possible induction of mania and hypomania by Olanzapine or Risperidone: a critical review of reported cases. J Clin Psychiatry 2000; 61: 649-655
82. Baldassano CF, Ballas C, Datto SM, Kim D, Littman L, O'Reardon J, Rynn MA. Ziprasidone-associated mania: a case series and review of the mechanism. Bipol Disord 2003; 5: 72-75
83. Benazzi F. Olanzapine-induced psychotic mania in bipolar schizo-affective disorder. Eur Psychiatry 1999; 14: 410-411
84. Ahmed Z, Anderson IM. Treatment of bipolar affective disorder in clinical practice. J Psychopharmacol 2001; 15/1: 5-57
85. Have M ten, Vollebergh W, Bijl R, Nolen WA. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2002; 68: 203-213
86. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146-1154
87. Sajatovic M, Brescan DW, Perez DE, DiGiovanni SK, Hattab H, Ray JB, Bingham CR. Quetiapine alone and added to amood stabilizer for serious mood disorders. J Clin Psychiatry 2001; 62: 728-732
88. Tohen M, Chengappa KNR, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59: 62-69
89. Goodnick PJ. The use of nimodipine in the treatment of mood disorders. Bipolar Disord 2000; 2: 165-173
90. Baumann B, Bogerts B. Neuroanatomical studies on bipolar disorder. Brit J Psychiatry 2001; 178, suppl 41: s142-s147
91. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear P, Adler CM. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 2002; 159: 1841-1847
92. Cecil KM, DelBello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipol Disord 2002; 4: 357-365
93. Moore PB, Sheperd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN. Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Brit J Psychiatry 2001; 178: 172-176
94. Blackwood DHR, Visscher PM, Muir WJ. Genetic studies of bipolar affective disorder in large families. Brit J Psychiatry 2001; 178, suppl 41: s134-s136
95. Quraishi S, Frabgou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002; 72: 209-226